Health Trials

Overall Response Rate

3

Review clinical trials related to Overall Response Rate. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions

The purpose of this study is to explore the efficacy and safety ofof bevacizumab plus cisplatin compare with cisplatin in the treatment of malignant serous effusion in patients with advanced adenocarcinoma

Participants needed: 60
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: Qingdao Central HospitalUpdated: Jul 29, 2025Locations: 1
Eligibility criteria

Voluntarily sign informed consent; [+3]

The subject had received anti-vascular endothelial growth factor (VEGF) small mo...

Read more
Status: Recruiting

Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)

Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc.

Participants needed: 3,000
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: The Second Affiliated Hospital of Hainan Medical UniversityUpdated: Feb 13, 2025Locations: 1
Eligibility criteria

Patients are undergoing or have undergone imaging or treatment at the MR linac; [+3]

Contraindications to MRI, such as claustrophobia and metallic or electronic impl... [+4]

Read more
Status: Recruiting

A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients

Evaluate the objective response rate (ORR) of the combination of candenizumab, lenvatinib, and SOX regimen for the treatment of HER2 negative advanced gastric or gastroesophageal junction adenocarcinoma patients

Participants needed: 50
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Fujian Medical UniversityUpdated: Feb 26, 2024Locations: 1
Eligibility criteria

Age: 18 years ≤ Age ≤ 75 years; [+14]

If a subject meets any of the following conditions, they will not be allowed to... [+14]

Read more